ArticleJAMA network open2022

Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.

Adam J Nelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.